333 related articles for article (PubMed ID: 32606172)
21. Neoadjuvant chemoradiotherapy might provide survival benefit in patients with stage IIIb/IIIc locally advanced rectal cancer: A retrospective single-institution study with propensity score-matched comparative analysis.
Sun XY; Cai SH; Xu L; Luo D; Qiu HZ; Wu B; Lin GL; Lu JY; Zhang GN; Xiao Y
Asia Pac J Clin Oncol; 2020 Jun; 16(3):142-149. PubMed ID: 32031326
[TBL] [Abstract][Full Text] [Related]
22. Combined Detection of RUNX3 and EZH2 in Evaluating Efficacy of Neoadjuvant Therapy and Prognostic Value of Middle and Low Locally Advanced Rectal Cancer.
Wang L; Wu X; Xu W; Gao L; Wang X; Li T
Front Oncol; 2022; 12():713335. PubMed ID: 35280723
[TBL] [Abstract][Full Text] [Related]
23. Significance of ypTNM stage in determining the prognosis and therapy after surgery for locally advanced rectal cancer.
Chen Y; Sun J; Dong X; Sun D; Qu Y
World J Surg Oncol; 2023 Jun; 21(1):174. PubMed ID: 37287039
[TBL] [Abstract][Full Text] [Related]
24. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
25. Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study.
Shaish H; Aukerman A; Vanguri R; Spinelli A; Armenta P; Jambawalikar S; Makkar J; Bentley-Hibbert S; Del Portillo A; Kiran R; Monti L; Bonifacio C; Kirienko M; Gardner KL; Schwartz L; Keller D
Eur Radiol; 2020 Nov; 30(11):6263-6273. PubMed ID: 32500192
[TBL] [Abstract][Full Text] [Related]
26. Oncologic and survival outcomes in elderly patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy and total mesorectal excision.
He F; Chen M; Xiao WW; Zhang Q; Liu Y; Zheng J; Wan XB; Gao YH
Jpn J Clin Oncol; 2021 Aug; 51(9):1391-1399. PubMed ID: 34155513
[TBL] [Abstract][Full Text] [Related]
27. Validation of the Neoadjuvant Rectal Cancer (NAR) Score for Prognostication Following Total Neoadjuvant Therapy (TNT) for Locally Advanced Rectal Cancer.
Shah S; Asawa P; Abel S; Wegner RE
J Gastrointest Cancer; 2023 Sep; 54(3):829-836. PubMed ID: 36253514
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of neoadjuvant rectal score-based signature nomograms to predict overall survival and disease-free survival in locally advanced rectal cancer: a retrospective, double center, cohort study.
Wang G; Tang Z; Ye J; Tang H; Yao K; Zeng Q; Yang Y; Fu M; Luo L; Shen Q; Fang X; Ling B; Fang Y; Guo Y; Huang Y
Int J Clin Oncol; 2023 Feb; 28(2):268-279. PubMed ID: 36534264
[TBL] [Abstract][Full Text] [Related]
29. High platelet × C-reactive protein level multiplier is a negative prognostic marker in rectal cancer treated by neoadjuvant chemoradiotherapy.
Ide S; Toiyama Y; Okugawa Y; Shimura T; Fujikawa H; Hiro J; Ohi M; Kusunoki M
Int J Clin Oncol; 2021 Apr; 26(4):708-716. PubMed ID: 33415573
[TBL] [Abstract][Full Text] [Related]
30. Retrospective survival analysis of stage II-III rectal cancer: tumour regression grade, grading and lymphovascular invasion are the only predictors.
Morini A; Annicchiarico A; Romboli A; Ricco' M; Crafa P; Montali F; Dell'Abate P; Costi R
ANZ J Surg; 2021 Mar; 91(3):E112-E118. PubMed ID: 33319510
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumour regression?
McCoy MJ; Hemmings C; Hillery S; Penter C; Bulsara MK; Zeps N; Platell CF
ANZ J Surg; 2017 Dec; 87(12):E233-E239. PubMed ID: 26631340
[TBL] [Abstract][Full Text] [Related]
32. The clinical relevance of adjuvant chemotherapy in locally advanced rectal cancer patients achieving near pathological complete response following neoadjuvant chemoradiotherapy: Insights from ypT stage.
Cai Y; Chen M; Ye F; Liu Z; Luo S; Huang L; Kang L
Eur J Surg Oncol; 2024 Apr; 50(4):108001. PubMed ID: 38364330
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of tumour regression grade in locally advanced rectal cancer: a systematic review and meta-analysis.
Kong JC; Guerra GR; Warrier SK; Lynch AC; Michael M; Ngan SY; Phillips W; Ramsay G; Heriot AG
Colorectal Dis; 2018 Jul; 20(7):574-585. PubMed ID: 29582537
[TBL] [Abstract][Full Text] [Related]
34. Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients.
Mei SW; Liu Z; Wei FZ; Chen JN; Wang ZJ; Shen HY; Li J; Zhao FQ; Pei W; Wang Z; Wang XS; Liu Q
World J Gastroenterol; 2020 Aug; 26(31):4624-4638. PubMed ID: 32884221
[TBL] [Abstract][Full Text] [Related]
35. Prognostic implication of the neoadjuvant rectal score and other biomarkers of clinical outcome in Hong Kong Chinese patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
Ho SSK; Hon SSF; Hung E; Lee JFY; Mo F; Tong M; So C; Chu S; Ng DCK; Lam D; Cho C; Mak TWC; Ng SSM; Futaba K; Suen J; To KF; Chan AWH; Yeung WWK; Ma BBY
Hong Kong Med J; 2022 Jun; 28(3):230-238. PubMed ID: 35667869
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.
Abdul-Jalil KI; Sheehan KM; Kehoe J; Cummins R; O'Grady A; McNamara DA; Deasy J; Breathnach O; Grogan L; O'Neill BD; Faul C; Parker I; Kay EW; Hennessy BT; Gillen P
Colorectal Dis; 2014 Jan; 16(1):O16-25. PubMed ID: 24119076
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of pretreatment systemic inflammatory markers in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy.
Zhang Y; Liu X; Xu M; Chen K; Li S; Guan G
Sci Rep; 2020 May; 10(1):8017. PubMed ID: 32415197
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer.
Jiang DM; Raissouni S; Mercer J; Kumar A; Goodwin R; Heng DY; Tang PA; Doll C; MacLean A; Powell E; Price-Hiller J; Monzon J; Cheung WY; Vickers MM
Ann Oncol; 2015 Oct; 26(10):2102-6. PubMed ID: 26232491
[TBL] [Abstract][Full Text] [Related]
39. Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy.
Wang Y; Zhang J; Zhou M; Yang L; Wan J; Shen L; Liang L; Yao Y; Zhang H; Zhang Z
Cancer Med; 2019 Apr; 8(4):1508-1520. PubMed ID: 30790459
[TBL] [Abstract][Full Text] [Related]
40. Increased lymph node yield indicates improved survival in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Wang Y; Zhou M; Yang J; Sun X; Zou W; Zhang Z; Zhang J; Shen L; Yang L; Zhang Z
Cancer Med; 2019 Aug; 8(10):4615-4625. PubMed ID: 31250569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
